ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

FIT More Effective Than gFOBT In All Colonoscopy Capacities

November 25, 2011

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

November 14, 1975

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

DCE Board Approves concepts For Grants to Develop HPV Animal Models, ALL Etiology Contracts

March 11, 1988

DCT Board Approves Concepts Of Five Contract Recompetitions

October 14, 1983